Bauer Dávid, Toušek Petr
Department of Cardiology, Third Faculty of Medicine, Charles University, University Hospital Královské Vinohrady, 100 34 Prague, Czech Republic.
J Clin Med. 2021 Oct 1;10(19):4574. doi: 10.3390/jcm10194574.
Defining the risk factors affecting the prognosis of patients with acute coronary syndrome (ACS) has been a challenge. Many individual biomarkers and risk scores that predict outcomes during different periods following ACS have been proposed. This review evaluates known outcome predictors supported by clinical data in light of the development of new treatment strategies for ACS patients during the last three decades.
确定影响急性冠状动脉综合征(ACS)患者预后的危险因素一直是一项挑战。已经提出了许多预测ACS后不同时期预后的个体生物标志物和风险评分。本综述根据过去三十年中针对ACS患者的新治疗策略的发展,评估了临床数据支持的已知预后预测因素。